APO Research
Talk to an analyst

APO RESEARCH · REPORT

Follicle Stimulating Hormone

Follicle stimulating hormone (FSH) is a hormone made by the pituitary gland that affects the gonads (female ovaries and males testes). In females, it stimulates growth of the ovarian follicles.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

Follicle stimulating hormone (FSH) is a hormone made by the pituitary gland that affects the gonads (female ovaries and males testes). In females, it stimulates growth of the ovarian follicles.

Selected research

Industry Growth & Trends

Global Follicle Stimulating Hormone Industry Growth and Trends Forecast to 2032

21 December 202595 pages

Choose your research edition.

Industry ResearchFollicle Stimulating Hormone Industry Research Report 2026116 pages · $2,950 USDIndustry Growth & TrendsGlobal Follicle Stimulating Hormone Industry Growth and Trends Forecast to 203295 pages · $3,450 USDMarket StructureGlobal Follicle Stimulating Hormone Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032184 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Follicle Stimulating Hormone Market Outlook and Growth Opportunities 2026190 pages · $4,250 USDMarket Analysis & ForecastGlobal Follicle Stimulating Hormone Market Analysis and Forecast 2026-2032196 pages · $4,950 USD

Market perspective

Follicle stimulating hormone (FSH) is a hormone made by the pituitary gland that affects the gonads (female ovaries and males testes). In females, it stimulates growth of the ovarian follicles.

Due to less pollution, recombinant FSH takes large proportion in market. In 2019, recombinant FSH takes about 82% of Poland follicle stimulating hormone consumption market share.

There are only several companies producing this product, such as Merck Serono, MSD, IBSA, Ferring, Livzon and Techwell etc. Merck Serono and MSD are Top 2 companies in the world. In 2019, Merck Serono takes about 55% of Poland follicle stimulating hormone revenue. MSD takes about 18% of Poland follicle stimulating hormone revenue.

Read the full market overview

Report Scope

This report provides a structured, data-driven view of the global Follicle Stimulating Hormone market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Follicle Stimulating Hormone market size, estimates, and forecasts are presented in terms of sales volume (k doses) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Follicle Stimulating Hormone market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant toFollicle Stimulating Hormone.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Follicle Stimulating Hormone market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Follicle Stimulating Hormone Market by Company

Merck Serono

MSD

IBSA

Ferring

Livzon

Techwell

GenSci

Gedeon Richter

Teva

Follicle Stimulating Hormone Segment by Type

Recombinant FSH

Urinary FSH

Follicle Stimulating Hormone Segment by Application

Infertility Treatment

Assisted Reproductive Technology

Follicle Stimulating Hormone Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Follicle Stimulating Hormone market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Follicle Stimulating Hormone and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Follicle Stimulating Hormone.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Follicle Stimulating Hormone manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Follicle Stimulating Hormone in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Recombinant FSH Table 2. Major Company of Urinary FSH Table 3. Global Follicle Stimulating Hormone Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Global Follicle Stimulating Hormone Sales by Type (2021-2026) & (k doses) Table 5. Global Follicle Stimulating Hormone Sales Market Share in Volume by Type (2021-2026) Table 6. Global Follicle Stimulating Hormone Sales by Type (2021-2026) & (US$ Million) Table 7. Global Follicle Stimulating Hormone Sales Market Share in Value by Type (2021-2026) Table 8. Global Follicle Stimulating Hormone Price by Type (2021-2026) & (USD/dose) Table 9. Global Follicle Stimulating Hormone Sales by Type (2027-2032) & (k doses) Table 10. Global Follicle Stimulating Hormone Sales Market Share in Volume by Type (2027-2032) Table 11. Global Follicle Stimulating Hormone Sales by Type (2027-2032) & (US$ Million) Table 12. Global Follicle Stimulating Hormone Sales Market Share in Value by Type (2027-2032) Table 13. Global Follicle Stimulating Hormone Price by Type (2027-2032) & (USD/dose) Table 14. North America Follicle Stimulating Hormone Sales by Type (2021-2026) & (k doses) Table 15. North America Follicle Stimulating Hormone Sales by Type (2021-2026) & (US$ Million) Table 16. Europe Follicle Stimulating Hormone Sales by Type (2021-2026) & (k doses) Table 17. Europe Follicle Stimulating Hormone Sales by Type (2021-2026) & (US$ Million) Table 18. Asia-Pacific Follicle Stimulating Hormone Sales by Type (2021-2026) & (k doses) Table 19. Asia-Pacific Follicle Stimulating Hormone Sales by Type (2021-2026) & (US$ Million) Table 20. Latin America Follicle Stimulating Hormone Sales by Type (2021-2026) & (k doses) Table 21. Latin America Follicle Stimulating Hormone Sales by Type (2021-2026) & (US$ Million) Table 22. Middle East and Africa Follicle Stimulating Hormone Sales by Type (2021-2026) & (k doses) Table 23. Middle East and Africa Follicle Stimulating Hormone Sales by Type (2021-2026) & (US$ Million) Table 24. Follicle Stimulating Hormone Industry Trends Table 25. Follicle Stimulating Hormone Industry Drivers Table 26. Follicle Stimulating Hormone Industry Opportunities and Challenges Table 27. Follicle Stimulating Hormone Industry Restraints Table 28. Global Follicle Stimulating Hormone Sales Revenue by Company (US$ Million) & (2021-2026) Table 29. Global Follicle Stimulating Hormone Revenue Market Share by Company (2021-2026) Table 30. Global Follicle Stimulating Hormone Sales by Company (2021-2026) & (k doses) Table 31. Global Follicle Stimulating Hormone Sales Share by Company (2021-2026) Table 32. Global Follicle Stimulating Hormone Market Price by Company (2021-2026) & (USD/dose) Table 33. Global Follicle Stimulating Hormone Industry Company Ranking, 2024 VS 2025 VS 2026 Table 34. Global Follicle Stimulating Hormone Major Company Production Sites and Headquarters Table 35. Global Follicle Stimulating Hormone Company, Product Type & Application Table 36. Global Follicle Stimulating Hormone Company Establishment Date Table 37. Global Company Market Concentration Ratio (CR5 and HHI) Table 38. Global Follicle Stimulating Hormone by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 39. Global Follicle Stimulating Hormone Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 40. Global Follicle Stimulating Hormone Sales by Region (2021-2026) & (k doses) Table 41. Global Follicle Stimulating Hormone Sales Market Share in Volume by Region (2021-2026) Table 42. Global Follicle Stimulating Hormone Sales by Region (2021-2026) & (US$ Million) Table 43. Global Follicle Stimulating Hormone Sales Market Share in Value by Region (2021-2026) Table 44. Global Follicle Stimulating Hormone Sales (k doses), Value (US$ Million), Price (USD/dose) and Gross Margin (2021-2026) Table 45. Global Follicle Stimulating Hormone Sales by Region (2027-2032) & (k doses) Table 46. Global Follicle Stimulating Hormone Sales Market Share in Volume by Region (2027-2032) Table 47. Global Follicle Stimulating Hormone Sales by Region (2027-2032) & (US$ Million) Table 48. Global Follicle Stimulating Hormone Sales Market Share in Value by Region (2027-2032) Table 49. Global Follicle Stimulating Hormone Sales (k doses), Value (US$ Million), Price (USD/dose) and Gross Margin (2027-2032) Table 50. Global Follicle Stimulating Hormone Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 51. Global Follicle Stimulating Hormone Sales by Application (2021-2026) & (k doses) Table 52. Global Follicle Stimulating Hormone Sales Market Share in Volume by Application (2021-2026) Table 53. Global Follicle Stimulating Hormone Sales by Application (2021-2026) & (US$ Million) Table 54. Global Follicle Stimulating Hormone Sales Market Share in Value by Application (2021-2026) Table 55. Global Follicle Stimulating Hormone Price by Application (2021-2026) & (USD/dose) Table 56. Global Follicle Stimulating Hormone Sales by Application (2027-2032) & (k doses) Table 57. Global Follicle Stimulating Hormone Sales Market Share in Volume by Application (2027-2032) Table 58. Global Follicle Stimulating Hormone Sales by Application (2027-2032) & (US$ Million) Table 59. Global Follicle Stimulating Hormone Sales Market Share in Value by Application (2027-2032) Table 60. Global Follicle Stimulating Hormone Price by Application (2027-2032) & (USD/dose) Table 61. North America Follicle Stimulating Hormone Sales by Application (2021-2026) & (k doses) Table 62. North America Follicle Stimulating Hormone Sales by Application (2021-2026) & (US$ Million) Table 63. Europe Follicle Stimulating Hormone Sales by Application (2021-2026) & (k doses) Table 64. Europe Follicle Stimulating Hormone Sales by Application (2021-2026) & (US$ Million) Table 65. Asia-Pacific Follicle Stimulating Hormone Sales by Application (2021-2026) & (k doses) Table 66. Asia-Pacific Follicle Stimulating Hormone Sales by Application (2021-2026) & (US$ Million) Table 67. Latin America Follicle Stimulating Hormone Sales by Application (2021-2026) & (k doses) Table 68. Latin America Follicle Stimulating Hormone Sales by Application (2021-2026) & (US$ Million) Table 69. Middle East and Africa Follicle Stimulating Hormone Sales by Application (2021-2026) & (k doses) Table 70. Middle East and Africa Follicle Stimulating Hormone Sales by Application (2021-2026) & (US$ Million) Table 71. Merck Serono Company Information Table 72. Merck Serono Business Overview Table 73. Merck Serono Follicle Stimulating Hormone Sales (k doses), Revenue (US$ Million), Price (USD/dose) and Gross Margin (2021-2026) Table 74. Merck Serono Follicle Stimulating Hormone Product Portfolio Table 75. Merck Serono Recent Development Table 76. MSD Company Information Table 77. MSD Business Overview Table 78. MSD Follicle Stimulating Hormone Sales (k doses), Revenue (US$ Million), Price (USD/dose) and Gross Margin (2021-2026) Table 79. MSD Follicle Stimulating Hormone Product Portfolio Table 80. MSD Recent Development Table 81. IBSA Company Information Table 82. IBSA Business Overview Table 83. IBSA Follicle Stimulating Hormone Sales (k doses), Revenue (US$ Million), Price (USD/dose) and Gross Margin (2021-2026) Table 84. IBSA Follicle Stimulating Hormone Product Portfolio Table 85. IBSA Recent Development Table 86. Ferring Company Information Table 87. Ferring Business Overview Table 88. Ferring Follicle Stimulating Hormone Sales (k doses), Revenue (US$ Million), Price (USD/dose) and Gross Margin (2021-2026) Table 89. Ferring Follicle Stimulating Hormone Product Portfolio Table 90. Ferring Recent Development Table 91. Livzon Company Information Table 92. Livzon Business Overview Table 93. Livzon Follicle Stimulating Hormone Sales (k doses), Revenue (US$ Million), Price (USD/dose) and Gross Margin (2021-2026) Table 94. Livzon Follicle Stimulating Hormone Product Portfolio Table 95. Livzon Recent Development Table 96. Techwell Company Information Table 97. Techwell Business Overview Table 98. Techwell Follicle Stimulating Hormone Sales (k doses), Revenue (US$ Million), Price (USD/dose) and Gross Margin (2021-2026) Table 99. Techwell Follicle Stimulating Hormone Product Portfolio Table 100. Techwell Recent Development Table 101. GenSci Company Information Table 102. GenSci Business Overview Table 103. GenSci Follicle Stimulating Hormone Sales (k doses), Revenue (US$ Million), Price (USD/dose) and Gross Margin (2021-2026) Table 104. GenSci Follicle Stimulating Hormone Product Portfolio Table 105. GenSci Recent Development Table 106. Gedeon Richter Company Information Table 107. Gedeon Richter Business Overview Table 108. Gedeon Richter Follicle Stimulating Hormone Sales (k doses), Revenue (US$ Million), Price (USD/dose) and Gross Margin (2021-2026) Table 109. Gedeon Richter Follicle Stimulating Hormone Product Portfolio Table 110. Gedeon Richter Recent Development Table 111. Teva Company Information Table 112. Teva Business Overview Table 113. Teva Follicle Stimulating Hormone Sales (k doses), Revenue (US$ Million), Price (USD/dose) and Gross Margin (2021-2026) Table 114. Teva Follicle Stimulating Hormone Product Portfolio Table 115. Teva Recent Development Table 116. North America Follicle Stimulating Hormone Market Size Growth Rate (CAGR) by Country (k doses): 2021 VS 2025 VS 2032 Table 117. North America Follicle Stimulating Hormone Sales by Country (2021-2026) & (k doses) Table 118. North America Follicle Stimulating Hormone Sales Market Share by Country (2021-2026) Table 119. North America Follicle Stimulating Hormone Sales Forecast by Country (2027-2032) & (k doses) Table 120. North America Follicle Stimulating Hormone Sales Market Share Forecast by Country (2027-2032) Table 121. North America Follicle Stimulating Hormone Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 122. North America Follicle Stimulating Hormone Market Size by Country (2021-2026) & (US$ Million) Table 123. North America Follicle Stimulating Hormone Market Share by Country (2021-2026) Table 124. North America Follicle Stimulating Hormone Market Size Forecast by Country (2027-2032) & (US$ Million) Table 125. North America Follicle Stimulating Hormone Market Share Forecast by Country (2027-2032) Table 126. Europe Follicle Stimulating Hormone Market Size Growth Rate (CAGR) by Country (k doses): 2021 VS 2025 VS 2032 Table 127. Europe Follicle Stimulating Hormone Sales by Country (2021-2026) & (k doses) Table 128. Europe Follicle Stimulating Hormone Sales Market Share by Country (2021-2026) Table 129. Europe Follicle Stimulating Hormone Sales Forecast by Country (2027-2032) & (k doses) Table 130. Europe Follicle Stimulating Hormone Sales Market Share Forecast by Country (2027-2032) Table 131. Europe Follicle Stimulating Hormone Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 132. Europe Follicle Stimulating Hormone Market Size by Country (2021-2026) & (US$ Million) Table 133. Europe Follicle Stimulating Hormone Market Share by Country (2021-2026) Table 134. Europe Follicle Stimulating Hormone Market Size Forecast by Country (2027-2032) & (US$ Million) Table 135. Europe Follicle Stimulating Hormone Market Share Forecast by Country (2027-2032) Table 136. Asia-Pacific Follicle Stimulating Hormone Market Size Growth Rate (CAGR) by Country (k doses): 2021 VS 2025 VS 2032 Table 137. Asia-Pacific Follicle Stimulating Hormone Sales by Country (2021-2026) & (k doses) Table 138. Asia-Pacific Follicle Stimulating Hormone Sales Market Share by Country (2021-2026) Table 139. Asia-Pacific Follicle Stimulating Hormone Sales Forecast by Country (2027-2032) & (k doses) Table 140. Asia-Pacific Follicle Stimulating Hormone Sales Market Share Forecast by Country (2027-2032) Table 141. Asia-Pacific Follicle Stimulating Hormone Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 142. Asia-Pacific Follicle Stimulating Hormone Market Size by Country (2021-2026) & (US$ Million) Table 143. Asia-Pacific Follicle Stimulating Hormone Market Share by Country (2021-2026) Table 144. Asia-Pacific Follicle Stimulating Hormone Market Size Forecast by Country (2027-2032) & (US$ Million) Table 145. Asia-Pacific Follicle Stimulating Hormone Market Share Forecast by Country (2027-2032) Table 146. Latin America Follicle Stimulating Hormone Market Size Growth Rate (CAGR) by Country (k doses): 2021 VS 2025 VS 2032 Table 147. Latin America Follicle Stimulating Hormone Sales by Country (2021-2026) & (k doses) Table 148. Latin America Follicle Stimulating Hormone Sales Market Share by Country (2021-2026) Table 149. Latin America Follicle Stimulating Hormone Sales Forecast by Country (2027-2032) & (k doses) Table 150. Latin America Follicle Stimulating Hormone Sales Market Share Forecast by Country (2027-2032) Table 151. Latin America Follicle Stimulating Hormone Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 152. Latin America Follicle Stimulating Hormone Market Size by Country (2021-2026) & (US$ Million) Table 153. Latin America Follicle Stimulating Hormone Market Share by Country (2021-2026) Table 154. Latin America Follicle Stimulating Hormone Market Size Forecast by Country (2027-2032) & (US$ Million) Table 155. Latin America Follicle Stimulating Hormone Market Share Forecast by Country (2027-2032) Table 156. Middle East and Africa Follicle Stimulating Hormone Market Size Growth Rate (CAGR) by Country (k doses): 2021 VS 2025 VS 2032 Table 157. Middle East and Africa Follicle Stimulating Hormone Sales by Country (2021-2026) & (k doses) Table 158. Middle East and Africa Follicle Stimulating Hormone Sales Market Share by Country (2021-2026) Table 159. Middle East and Africa Follicle Stimulating Hormone Sales Forecast by Country (2027-2032) & (k doses) Table 160. Middle East and Africa Follicle Stimulating Hormone Sales Market Share Forecast by Country (2027-2032) Table 161. Middle East and Africa Follicle Stimulating Hormone Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 162. Middle East and Africa Follicle Stimulating Hormone Market Size by Country (2021-2026) & (US$ Million) Table 163. Middle East and Africa Follicle Stimulating Hormone Market Share by Country (2021-2026) Table 164. Middle East and Africa Follicle Stimulating Hormone Market Size Forecast by Country (2027-2032) & (US$ Million) Table 165. Middle East and Africa Follicle Stimulating Hormone Market Share Forecast by Country (2027-2032) Table 166. Key Raw Materials Table 167. Raw Materials Key Suppliers Table 168. Follicle Stimulating Hormone Distributors List Table 169. Follicle Stimulating Hormone Customers List Table 170. Research Programs/Design for This Report Table 171. Authors List of This Report Table 172. Secondary Sources Table 173. Primary Sources List of Figures Figure 1. Follicle Stimulating Hormone Image Figure 2. Global Follicle Stimulating Hormone Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Follicle Stimulating Hormone Market Size (2021-2032) & (US$ Million) Figure 4. Global Follicle Stimulating Hormone Sales (2021-2032) & (k doses) Figure 5. Recombinant FSH Image Figure 6. Global Recombinant FSH Sales YoY Growth (2021-2032) & (k doses) Figure 7. Urinary FSH Image Figure 8. Global Urinary FSH Sales YoY Growth (2021-2032) & (k doses) Figure 9. Global Follicle Stimulating Hormone Market Size Overview by Type (2021-2032) & (US$ Million) Figure 10. Global Follicle Stimulating Hormone Market Share by Type 2025 VS 2032 Figure 11. North America Follicle Stimulating Hormone Sales Market Share in Volume by Type in 2025 Figure 12. North America Follicle Stimulating Hormone Sales Market Share in Value by Type in 2025 Figure 13. Europe Follicle Stimulating Hormone Sales Market Share in Volume by Type in 2025 Figure 14. Europe Follicle Stimulating Hormone Sales Market Share in Value by Type in 2025 Figure 15. Asia-Pacific Follicle Stimulating Hormone Sales Market Share in Volume by Type in 2025 Figure 16. Asia-Pacific Follicle Stimulating Hormone Sales Market Share in Value by Type in 2025 Figure 17. Latin America Follicle Stimulating Hormone Sales Market Share in Volume by Type in 2025 Figure 18. Latin America Follicle Stimulating Hormone Sales Market Share in Value by Type in 2025 Figure 19. Middle East and Africa Follicle Stimulating Hormone Sales Market Share in Volume by Type in 2025 Figure 20. Middle East and Africa Follicle Stimulating Hormone Sales Market Share in Value by Type in 2025 Figure 21. Global Top 5 and 10 Follicle Stimulating Hormone Players Market Share by Revenue in 2025 Figure 22. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 23. Infertility Treatment Image Figure 24. Global Infertility Treatment Sales YoY Growth (2021-2032) & (k doses) Figure 25. Assisted Reproductive Technology Image Figure 26. Global Assisted Reproductive Technology Sales YoY Growth (2021-2032) & (k doses) Figure 27. Global Follicle Stimulating Hormone Market Size Overview by Application (2021-2032) & (US$ Million) Figure 28. Global Follicle Stimulating Hormone Market Share by Application 2025 VS 2032 Figure 29. North America Follicle Stimulating Hormone Sales Market Share in Volume by Application in 2025 Figure 30. North America Follicle Stimulating Hormone Sales Market Share in Value by Application in 2025 Figure 31. Europe Follicle Stimulating Hormone Sales Market Share in Volume by Application in 2025 Figure 32. Europe Follicle Stimulating Hormone Sales Market Share in Value by Application in 2025 Figure 33. Asia-Pacific Follicle Stimulating Hormone Sales Market Share in Volume by Application in 2025 Figure 34. Asia-Pacific Follicle Stimulating Hormone Sales Market Share in Value by Application in 2025 Figure 35. Latin America Follicle Stimulating Hormone Sales Market Share in Volume by Application in 2025 Figure 36. Latin America Follicle Stimulating Hormone Sales Market Share in Value by Application in 2025 Figure 37. Middle East and Africa Follicle Stimulating Hormone Sales Market Share in Volume by Application in 2025 Figure 38. Middle East and Africa Follicle Stimulating Hormone Sales Market Share in Value by Application in 2025 Figure 39. North America Follicle Stimulating Hormone Sales by Country: 2021 VS 2025 VS 2032 (k doses) Figure 40. North America Follicle Stimulating Hormone Sales Share by Country: 2021 VS 2025 VS 2032 Figure 41. North America Follicle Stimulating Hormone Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 42. North America Follicle Stimulating Hormone Market Share by Country: 2021 VS 2025 VS 2032 Figure 43. Europe Follicle Stimulating Hormone Sales by Country: 2021 VS 2025 VS 2032 (k doses) Figure 44. Europe Follicle Stimulating Hormone Sales Share by Country: 2021 VS 2025 VS 2032 Figure 45. Europe Follicle Stimulating Hormone Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 46. Europe Follicle Stimulating Hormone Market Share by Country: 2021 VS 2025 VS 2032 Figure 47. Asia-Pacific Follicle Stimulating Hormone Sales by Country: 2021 VS 2025 VS 2032 (k doses) Figure 48. Asia-Pacific Follicle Stimulating Hormone Sales Share by Country: 2021 VS 2025 VS 2032 Figure 49. Asia-Pacific Follicle Stimulating Hormone Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 50. Asia-Pacific Follicle Stimulating Hormone Market Share by Country: 2021 VS 2025 VS 2032 Figure 51. Latin America Follicle Stimulating Hormone Sales by Country: 2021 VS 2025 VS 2032 (k doses) Figure 52. Latin America Follicle Stimulating Hormone Sales Share by Country: 2021 VS 2025 VS 2032 Figure 53. Latin America Follicle Stimulating Hormone Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. Latin America Follicle Stimulating Hormone Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Middle East and Africa Follicle Stimulating Hormone Sales by Country: 2021 VS 2025 VS 2032 (k doses) Figure 56. Middle East and Africa Follicle Stimulating Hormone Sales Share by Country: 2021 VS 2025 VS 2032 Figure 57. Middle East and Africa Follicle Stimulating Hormone Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Middle East and Africa Follicle Stimulating Hormone Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Follicle Stimulating Hormone Value Chain Figure 60. Key Raw Materials Price Figure 61. Manufacturing Cost Structure Figure 62. Follicle Stimulating Hormone Production Mode & Process Figure 63. Direct Comparison with Distribution Share Figure 64. Distributors Profiles Figure 65. Years Considered Figure 66. Research Process Figure 67. Key Executives Interviewed

Scope & coverage.

Types
  • Recombinant FSH
  • Urinary FSH
Applications
  • Infertility Treatment
  • Assisted Reproductive Technology
Companies covered
  • Merck Serono
  • MSD
  • IBSA
  • Ferring
  • Livzon
  • Techwell
  • GenSci
  • Gedeon Richter
  • Teva

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Follicle Stimulating Hormone Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Follicle Stimulating Hormone Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Follicle Stimulating Hormone Market by Type
  6. 1.3.1 Recombinant FSH
  7. 1.3.2 Urinary FSH
  8. 1.4 Global Follicle Stimulating Hormone Market Size by Type
  9. 1.4.1 Global Follicle Stimulating Hormone Market Size Overview by Type (2021-2032)
  10. 1.4.2 Global Follicle Stimulating Hormone Historic Market Size Review by Type (2021-2026)
  11. 1.4.3 Global Follicle Stimulating Hormone Forecasted Market Size by Type (2027-2032)
  12. 1.5 Key Regions Market Size by Type
  13. 1.5.1 North America Follicle Stimulating Hormone Sales Breakdown by Type (2021-2026)
  14. 1.5.2 Europe Follicle Stimulating Hormone Sales Breakdown by Type (2021-2026)
  15. 1.5.3 Asia-Pacific Follicle Stimulating Hormone Sales Breakdown by Type (2021-2026)
  16. 1.5.4 South America Follicle Stimulating Hormone Sales Breakdown by Type (2021-2026)
  17. 1.5.5 Middle East and Africa Follicle Stimulating Hormone Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Follicle Stimulating Hormone Industry Trends
  2. 2.2 Follicle Stimulating Hormone Industry Drivers
  3. 2.3 Follicle Stimulating Hormone Industry Opportunities and Challenges
  4. 2.4 Follicle Stimulating Hormone Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Follicle Stimulating Hormone Revenue (2021-2026)
  2. 3.2 Global Top Players by Follicle Stimulating Hormone Sales (2021-2026)
  3. 3.3 Global Top Players by Follicle Stimulating Hormone Price (2021-2026)
  4. 3.4 Global Follicle Stimulating Hormone Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Follicle Stimulating Hormone Major Company Production Sites & Headquarters
  6. 3.6 Global Follicle Stimulating Hormone Company, Product Type & Application
  7. 3.7 Global Follicle Stimulating Hormone Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Follicle Stimulating Hormone Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Follicle Stimulating Hormone Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Follicle Stimulating Hormone Tier 1, Tier 2, and Tier 3
4 Follicle Stimulating Hormone Regional Status and Outlook
  1. 4.1 Global Follicle Stimulating Hormone Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Follicle Stimulating Hormone Historic Market Size by Region
  3. 4.2.1 Global Follicle Stimulating Hormone Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Follicle Stimulating Hormone Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Follicle Stimulating Hormone Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Follicle Stimulating Hormone Forecasted Market Size by Region
  7. 4.3.1 Global Follicle Stimulating Hormone Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Follicle Stimulating Hormone Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Follicle Stimulating Hormone Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Follicle Stimulating Hormone by Application
  1. 5.1 Follicle Stimulating Hormone Market by Application
  2. 5.1.1 Infertility Treatment
  3. 5.1.2 Assisted Reproductive Technology
  4. 5.2 Global Follicle Stimulating Hormone Market Size by Application
  5. 5.2.1 Global Follicle Stimulating Hormone Market Size Overview by Application (2021-2032)
  6. 5.2.2 Global Follicle Stimulating Hormone Historic Market Size Review by Application (2021-2026)
  7. 5.2.3 Global Follicle Stimulating Hormone Forecasted Market Size by Application (2027-2032)
  8. 5.3 Key Regions Market Size by Application
  9. 5.3.1 North America Follicle Stimulating Hormone Sales Breakdown by Application (2021-2026)
  10. 5.3.2 Europe Follicle Stimulating Hormone Sales Breakdown by Application (2021-2026)
  11. 5.3.3 Asia-Pacific Follicle Stimulating Hormone Sales Breakdown by Application (2021-2026)
  12. 5.3.4 South America Follicle Stimulating Hormone Sales Breakdown by Application (2021-2026)
  13. 5.3.5 Middle East and Africa Follicle Stimulating Hormone Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Merck Serono
  2. 6.1.1 Merck Serono Company Information
  3. 6.1.2 Merck Serono Business Overview
  4. 6.1.3 Merck Serono Follicle Stimulating Hormone Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Merck Serono Follicle Stimulating Hormone Product Portfolio
  6. 6.1.5 Merck Serono Recent Developments
  7. 6.2 MSD
  8. 6.2.1 MSD Company Information
  9. 6.2.2 MSD Business Overview
  10. 6.2.3 MSD Follicle Stimulating Hormone Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 MSD Follicle Stimulating Hormone Product Portfolio
  12. 6.2.5 MSD Recent Developments
  13. 6.3 IBSA
  14. 6.3.1 IBSA Company Information
  15. 6.3.2 IBSA Business Overview
  16. 6.3.3 IBSA Follicle Stimulating Hormone Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 IBSA Follicle Stimulating Hormone Product Portfolio
  18. 6.3.5 IBSA Recent Developments
  19. 6.4 Ferring
  20. 6.4.1 Ferring Company Information
  21. 6.4.2 Ferring Business Overview
  22. 6.4.3 Ferring Follicle Stimulating Hormone Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Ferring Follicle Stimulating Hormone Product Portfolio
  24. 6.4.5 Ferring Recent Developments
  25. 6.5 Livzon
  26. 6.5.1 Livzon Company Information
  27. 6.5.2 Livzon Business Overview
  28. 6.5.3 Livzon Follicle Stimulating Hormone Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Livzon Follicle Stimulating Hormone Product Portfolio
  30. 6.5.5 Livzon Recent Developments
  31. 6.6 Techwell
  32. 6.6.1 Techwell Company Information
  33. 6.6.2 Techwell Business Overview
  34. 6.6.3 Techwell Follicle Stimulating Hormone Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Techwell Follicle Stimulating Hormone Product Portfolio
  36. 6.6.5 Techwell Recent Developments
  37. 6.7 GenSci
  38. 6.7.1 GenSci Company Information
  39. 6.7.2 GenSci Business Overview
  40. 6.7.3 GenSci Follicle Stimulating Hormone Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 GenSci Follicle Stimulating Hormone Product Portfolio
  42. 6.7.5 GenSci Recent Developments
  43. 6.8 Gedeon Richter
  44. 6.8.1 Gedeon Richter Company Information
  45. 6.8.2 Gedeon Richter Business Overview
  46. 6.8.3 Gedeon Richter Follicle Stimulating Hormone Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Gedeon Richter Follicle Stimulating Hormone Product Portfolio
  48. 6.8.5 Gedeon Richter Recent Developments
  49. 6.9 Teva
  50. 6.9.1 Teva Company Information
  51. 6.9.2 Teva Business Overview
  52. 6.9.3 Teva Follicle Stimulating Hormone Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 Teva Follicle Stimulating Hormone Product Portfolio
  54. 6.9.5 Teva Recent Developments
7 North America by Country
  1. 7.1 North America Follicle Stimulating Hormone Sales by Country
  2. 7.1.1 North America Follicle Stimulating Hormone Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Follicle Stimulating Hormone Sales by Country (2021-2026)
  4. 7.1.3 North America Follicle Stimulating Hormone Sales Forecast by Country (2027-2032)
  5. 7.2 North America Follicle Stimulating Hormone Market Size by Country
  6. 7.2.1 North America Follicle Stimulating Hormone Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Follicle Stimulating Hormone Market Size by Country (2021-2026)
  8. 7.2.3 North America Follicle Stimulating Hormone Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Follicle Stimulating Hormone Sales by Country
  2. 8.1.1 Europe Follicle Stimulating Hormone Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Follicle Stimulating Hormone Sales by Country (2021-2026)
  4. 8.1.3 Europe Follicle Stimulating Hormone Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Follicle Stimulating Hormone Market Size by Country
  6. 8.2.1 Europe Follicle Stimulating Hormone Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Follicle Stimulating Hormone Market Size by Country (2021-2026)
  8. 8.2.3 Europe Follicle Stimulating Hormone Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Follicle Stimulating Hormone Sales by Country
  2. 9.1.1 Asia-Pacific Follicle Stimulating Hormone Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Follicle Stimulating Hormone Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Follicle Stimulating Hormone Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Follicle Stimulating Hormone Market Size by Country
  6. 9.2.1 Asia-Pacific Follicle Stimulating Hormone Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Follicle Stimulating Hormone Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Follicle Stimulating Hormone Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Follicle Stimulating Hormone Sales by Country
  2. 10.1.1 South America Follicle Stimulating Hormone Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Follicle Stimulating Hormone Sales by Country (2021-2026)
  4. 10.1.3 South America Follicle Stimulating Hormone Sales Forecast by Country (2027-2032)
  5. 10.2 South America Follicle Stimulating Hormone Market Size by Country
  6. 10.2.1 South America Follicle Stimulating Hormone Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Follicle Stimulating Hormone Market Size by Country (2021-2026)
  8. 10.2.3 South America Follicle Stimulating Hormone Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Follicle Stimulating Hormone Sales by Country
  2. 11.1.1 Middle East and Africa Follicle Stimulating Hormone Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Follicle Stimulating Hormone Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Follicle Stimulating Hormone Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Follicle Stimulating Hormone Market Size by Country
  6. 11.2.1 Middle East and Africa Follicle Stimulating Hormone Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Follicle Stimulating Hormone Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Follicle Stimulating Hormone Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Follicle Stimulating Hormone Value Chain Analysis
  2. 12.1.1 Follicle Stimulating Hormone Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Follicle Stimulating Hormone Production Mode & Process
  7. 12.2 Follicle Stimulating Hormone Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Follicle Stimulating Hormone Distributors
  10. 12.2.3 Follicle Stimulating Hormone Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst